Haoxi Health Technology Financials - Benzinga

Haoxi Health Technology Ltd

HAONASDAQ

Trade with Public

Trade with Public

$2.90

-0.07-2.36%

Últ. Act.: Sep 25, 12:55 PM

Panorámica general Noticias Previsión de beneficiosFinanzasSentimiento Propiedad Comparar Informe de acciones

Haoxi Health Technology Financials

Haoxi Health Technology (HAO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Dow Jumps 300 POints; Amazon Posts Upbeat Earnings

US stocks mixed as Dow gains 300 points, Amazon reports upbeat Q1 results. Industrials up 1.5%, tech down 0.8%. Oil down 1%, gold up 1.7%.

Avi Kapoor

PRO
Haoxi Health Technology FY EPS $0.04, Same YoY, Sales $48.52M Up From $28.23M YoY

Haoxi Health Technology (NASDAQ:HAO) reported quarterly earnings of $0.04 per share. This is unchanged from the same period last year. The company reported $48.52 million in sales this quarter. This is a 71.87 percent

Benzinga Newsdesk

PRO
Haoxi Health Technology Announces Preliminary FY24 Revenue Of ~$48.52M Up From $28.23M YoY

Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced preliminary unaudited financial results for the fiscal year ended June 30,

Benzinga Newsdesk

Dow Jumps Over 500 Points; FactSet Research Posts Upbeat Earnings

Avi Kapoor

PRO
Haoxi Health Technology 2H 2023 EPS $0.03 Vs $0.02 YoY; Revenue $23.5M Vs $9.16M YoY

Financial Highlights for the Six Months Ended December 31, 2023Total revenue for the six months ended December 31, 2023 was US$23.50 million, increased by US$14.34 million, or 157%, from US$9.16 million for the same

Benzinga Newsdesk

ETFs to Watch April 17, 2013 (CVY, GDXJ, SMH)

Benzinga

© 2026 Benzinga | All Rights Reserved